-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Tenet Healthcare, Raises Price Target to $307

Benzinga·10/16/2026 12:31:29
Listen to the news
Guggenheim analyst Jason Cassorla maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $283 to $307.